Drug Profile
Ibuprofen/paracetamol - Wellesley Pharmaceuticals
Alternative Names: PaxerolLatest Information Update: 18 Oct 2021
Price :
$50
*
At a glance
- Originator Wellesley Pharmaceuticals
- Class Acetanilides; Amines; Aminophenols; Anti-inflammatories; Antipyretics; Non-opioid analgesics; Phenylpropionates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Prostaglandin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Nocturia
Most Recent Events
- 18 Oct 2021 Discontinued - Phase-II for Nocturia in USA (PO)
- 01 Nov 2017 Wellesley Pharmaceuticals completes a phase II trial in Nocturia in USA (PO) (NCT02646826)
- 01 Jan 2016 Phase-II clinical trials in Nocturia in USA (PO) (NCT02646826)